Short answer
Quantum-Si Inc (QSI) filed an 8-K current report with the SEC on November 5, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1), Item EX-99.2 (Exhibit EX-99.2). Q3 and nine-month results announced for periods ended September 30, 2026.
Quantum-Si Inc 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q3 and nine-month results announced for periods ended September 30, 2026
- Business update included alongside the earnings release
- Detailed financial results and outlook available in Exhibit 99.1
- Non-GAAP measure methodology provided in Exhibit 99.2
Item EX-99.1 · Exhibit EX-99.1
- Q3 revenue $212,000, down from $552,000, reflecting Platinum-to-Proteus transition and near-term demand disruption
- Proteus remains targeted for Q2 2027 launch, with 19 amino acids detected and pre-orders now open
- Q3 adjusted operating expenses $18.2 million, down from $21.4 million, while restructuring affected approximately 20% of headcount
- 2026 guidance lowered: adjusted operating expenses $87.0 million or less and cash usage $87.0 million or less
- Cash, equivalents and investments $149.4 million, supporting operations into Q4 2028 under the current plan
Item EX-99.2 · Exhibit EX-99.2
- Press release covers Q3 and nine months ended September 30, 2026, with results announced November 5, 2026
- Adjusted EBITDA and adjusted total operating expenses provided as supplemental performance metrics
- Adjusted measures exclude stock-based compensation, restructuring, legal settlement and other non-recurring costs
- Investors should prioritize GAAP net loss and total operating expenses alongside non-GAAP reconciliations
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Quantum-Si Inc 8-K filings
Get the next QSI 8-K as it lands
Follow QSI for push alerts, or ask the research agent what this filing means.